- Home
- SDHC vs COYA Comparison
SDHC vs COYA Comparison
Compare SDHC & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDHC | COYA |
|---|---|---|
| Founded | 2008 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.3M | 97.8M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SDHC | COYA |
|---|---|---|
| Price | $13.16 | $4.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $14.60 | ★ $15.80 |
| AVG Volume (30 Days) | 77.6K | ★ 145.6K |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $971,116,000.00 | $7,945,753.00 |
| Revenue This Year | $4.21 | N/A |
| Revenue Next Year | $11.07 | $763.10 |
| P/E Ratio | $216.67 | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $11.13 | $3.71 |
| 52 Week High | $23.50 | $7.75 |
Technical Indicators
Market Signals| Indicator | SDHC | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 47.36 |
| Support Level | $11.18 | $3.90 |
| Resistance Level | $15.45 | $5.14 |
| Average True Range (ATR) | 0.90 | 0.26 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 16.37 | 19.61 |
Price Performance
Historical ComparisonAbout SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corpis a builder of single-family homes in communities in certain markets in the southeastern and southern United States. The Company's homes and communities are targeted to first-time and empty-nest homebuyers. The Company currently operates in metropolitan Atlanta, Birmingham, Chattanooga, Central Georgia, Charlotte, Dallas-Fort Worth, Greenville, Alabama Gulf Coast, Huntsville, Nashville, Raleigh and Houston. Its operations are currently organized into ten geographical divisions which comprise two reportable segments. Its Southeast segment consists of its Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of its Alabama, Dallas-Fort Worth, Houston, Nashville, and Alabama Gulf Coast divisions.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.